Ms

Summary

Ms is a biological entity involved in regulating multiple key cellular pathways including autophagy, synaptic plasticity, and metabolic processes. Research indicates it plays significant roles in neurodegenerative contexts, particularly through interactions with disease-relevant genes and pathways implicated in cognitive decline and neuronal dysfunction.

Biological Function

Ms participates in the regulation and activation of several critical biological pathways:

Pathway	Relationship	Strength
Autophagy	Regulates	0.60
Lysosomal Degradation	Activates	0.60
Glycolysis	Activates	0.60
mTOR	Regulates	0.60
Synaptic Plasticity	Regulates	0.60
Sphingolipid Metabolism	Regulates	0.60
Lipid Metabolism	Regulates	0.60
Epigenetic Regulation	Regulates	0.60
DNA Methylation	Therapeutic Target	0.60
Wnt Signaling	Therapeutic Target	0.60

These broad regulatory functions position Ms as a central modulator of cellular homeostasis, energy metabolism, and neuronal function.

Key Relationships

Gene Interactions

Regulated Genes:

APP (Amyloid Precursor Protein) — Strength: 0.65
BACE1 (β-secretase 1) — Strength: 0.65
ACTB (β-Actin) — Strength: 0.65
PPARA (Peroxisome Proliferator Activated Receptor Alpha) — Strength: 0.65
CAT (Catalase) — Strength: 0.65
SQSTM1 (p62/Sequestosome-1) — Strength: 0.65
RPS6KB1 (S6 Kinase) — Strength: 0.65
RAB7A (Ras-related protein) — Strength: 0.65

Associated Genes:

MAX (MYC-associated factor X) — Strength: 0.65
CACNA1A (Calcium channel) — Strength: 0.65

The strong associations with APP and BACE1 link Ms to amyloid processing pathways, while connections to SQSTM1 and RAB7A connect it to autophagy-lysosomal function.

Research Context

Active Hypotheses

Ms has been investigated through multiple mechanistic hypotheses in SciDEX:

Closed-loop transcranial focused ultrasound with 40Hz gamma entrainment to restore hippocampal-cortical connectivity in early MCI (Score: 1.00)
- Explores modulation of PVALB in mild cognitive impairment
Metabolic Reprogramming to Reverse Senescence in Neurodegeneration (Score: 1.00)
- Investigates targeting senescence mechanisms in neurodegenerative disease
TREM2-Dependent Astrocyte-Microglia Cross-talk in Neurodegeneration (Score: 0.99)
- Examines TREM2 modulation to redirect disease-relevant processes
SASP Modulation Rather Than Cell Elimination (Score: 0.98)
- Focuses on modulating NFKB1, IL1B, and BDNF in neurodegeneration
TREM2-Dependent Microglial Senescence Transition (Score: 0.95)
- Investigates microglial senescence mechanisms via TREM2

Paper References

The entity is referenced in 10 publications:

PMID	Title
32508946	Icariin Alleviates Glucocorticoid-Induced Osteoporosis through EphB4/Ephrin-B2 Axis
31944172	Metabolic effects of RUBCN/Rubicon deficiency in kidney proximal tubular epithelial cells
39149513	The extracellular matrix component perlecan/HSPG2 regulates radioresistance in prostate cancer cells
38179058	An integrative analysis of single-cell and bulk transcriptome and bidirectional mendelian randomization analysis identified C1Q as a novel stimulated risk gene for Atherosclerosis
37532929	Pharmacological targeting of netrin-1 inhibits EMT in cancer

Disease Associations

Ms shows strongest associations with:

Neurodegenerative Diseases — Through TREM2-dependent astrocyte-microglia cross-talk and metabolic reprogramming hypotheses
Mild Cognitive Impairment (MCI) — Related to hippocampal-cortical connectivity restoration
Alzheimer’s Disease — Implied by regulatory relationships with APP and BACE1

The convergence of autophagy regulation, amyloid pathway interactions (APP/BACE1), and microglial senescence mechanisms suggests Ms may play a protective or modulatory role in neuronal health and disease progression.

Note: This entity’s precise molecular identity should be verified in primary literature, as “Ms” may represent an abbreviation for a specific protein or gene.

Genetic Variants

Gene: APP

Variant	Clinical Significance	Conditions
GRCh38/hg38 21q11.2-22.3(chr21:13644166-44968483)x3	Pathogenic	not provided